DR. OLOF HEIMBURGER

1. Do you have, or have you had during the past 2 years, any formal association with a company or other interested party?
No

2. Do you have, or have you had during the past 2 years, any of the following types of association with a company or other interested party?
Giving expert/scientific advice

Date

2018- 2018

Company or interest group

Astra Zeneca

Value

Less than EUR 1,000

Payment made to

Personal account

Date

2018- 2018

Company or interest group

Vifor Pharma

Value

EUR 1,000-10,000

Payment made to

Personal account

Date

2019- 2019

Company or interest group

Opterion

Value

Less than EUR 1,000

Payment made to

Personal account
Lecturing, chairing lectures or participation in symposia/panel discussions

Date

2018- 2018

Company or interest group

Baxter Healthcare

Value

EUR 1,000-10,000

Payment made to

Personal account

Date

2018- 2018

Company or interest group

Fresenius Medical care

Value

EUR 1,000-10,000

Payment made to

Personal account

Date

2018- 2018

Company or interest group

Vifor

Value

EUR 1,000-10,000

Payment made to

Personal account

Date

2018- 2018

Company or interest group

Astra Zeneca

Value

Less than EUR 1,000

Payment made to

Personal account

Date

2019- 2019

Company or interest group

Adcock Ingram Intesive care

Value

EUR 1,000-10,000

Payment made to

Personal account

3. Do you have, or have you had during the past 2 years, any job, position, research grant, or other grant that involved a company or other interested party?
Principal investigator

Date

2018- 2018

Company or interest group

Astra Zeneca

Value

EUR 1,000-10,000

Payment made to

Hospital/institution

Nature of interest

Principal Investigator in clinical trial

Nature of restriction

Restricted: restricted to this trial

Date

2018- 2018

Company or interest group

Otsuka

Value

EUR 1,000-10,000

Payment made to

Hospital/institution

Nature of interest

Principal investigator in clinical trial

Nature of restriction

Restricted: to this trial

Date

2019- 2019

Company or interest group

Triomed

Value

EUR 1,000-10,000

Payment made to

Hospital/institution

Nature of interest

Principal investigator in clinical trial

Nature of restriction

Restricted: for costs of the trial
Other position in clinical trial

Date

2018- 2019

Company or interest group

Glaxo Smith Kline

Value

EUR 1,000-10,000

Payment made to

Hospital/institution

Nature of interest

subinvestigator in clinical trial

Nature of restriction

Restricted: to this trial

4. Other potential conflicts of interest?
No

5. Is there anything else that might influence your judgement, or might be perceived to do so?
No

6. Member (current) of any kind of committee, board, WG, etc. of another scientific association with similar aims as ERA-EDTA
No